NASDAQ · CANC
Tema Oncology ETF
$42.29-$0.06 (-0.15%)
Tema Oncology ETF’s quoted price sits in the upper half of its reported 52-week range, 10.02% below the high.
Loading market information…
CBOE · OVLH · USD
Stock price, dividends
Quote as of Oct 30, 2026, 07:15 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Overlay Shares Hedged Large Cap Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 3.29% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Overlay Shares Hedged Large Cap Equity ETF’s forward annual dividend is $0.12 per share, paid annual. The forward yield is 0.28% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The fund is an actively-managed exchange-traded fund (“ETF”) that seeks to achieve its objective by (i) investing in one or more other ETFs that seek to obtain exposure to the performance of U.S. large-cap equity securities or directly in the securities held by such ETFs (collectively, the “Underlying Investments”), and (ii) purchasing long-term out-of-the-money put options (i.e., put options with a strike price below the current price of the reference asset) to seek to hedge against significant declines in U.S. large-cap equities.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 11:36 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$42.29-$0.06 (-0.15%)
Tema Oncology ETF’s quoted price sits in the upper half of its reported 52-week range, 10.02% below the high.
$42.74-$0.89 (-2.04%)
Matthews Asia Innovators Active ETF’s quoted price sits in the lower half of its reported 52-week range, 29.97% below the high.
$14.32-$0.58 (-3.89%)
Nicholas Global Equity and Income ETF’s quoted price sits in the lower half of its reported 52-week range, 23.73% below the high.
$12.65-$0.44 (-3.36%)
Amplify Lithium & Battery Technology ETF’s quoted price sits in the lower half of its reported 52-week range, 30.03% below the high.
$35.19-$0.26 (-0.74%)
Pacer Swan SOS Moderate (January) ETF’s quoted price sits in the upper half of its reported 52-week range, 0.94% below the high.
$48.53-$0.60 (-1.22%)
AllianzIM U.S. Equity Buffer10 Jul ETF’s quoted price sits in the upper half of its reported 52-week range, 1.96% below the high.
$40.65-$0.68 (-1.65%)
Invesco S&P 500 Downside Hedged ETF’s quoted price sits in the upper half of its reported 52-week range, 6.85% below the high.
$56.57-$0.81 (-1.4%)
ProShares - Online Retail ETF’s quoted price sits in the lower half of its reported 52-week range, 11.53% below the high.
